Lysine-Specific Demethylase 1 Has Dual Functions as a Major Regulator of Androgen Receptor Transcriptional Activity-Reference-Cited by-同舟云学术

Lysine-Specific Demethylase 1 Has Dual Functions as a Major Regulator of Androgen Receptor Transcriptional Activity

Published:2014-12 Issue:5 Volume:9 Page:1618-1627
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Cai Changmeng,He Housheng Hansen,Gao Shuai,Chen Sen,Yu Ziyang,Gao Yanfei,Chen Shaoyong,Chen Mei Wei,Zhang Jesse,Ahmed Musaddeque,Wang Yang,Metzger Eric,Schüle Roland,Liu X. Shirley,Brown Myles,Balk Steven P.

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference35 articles.

1. Dynamic nucleosome-depleted regions at androgen receptor enhancers in the absence of ligand in prostate cancer cells;Andreu-Vieyra;Mol. Cell. Biol.,2011

2. Androgen receptor gene expression in prostate cancer is directly suppressed by the androgen receptor through recruitment of lysine-specific demethylase 1;Cai;Cancer Cell,2011

3. Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1;Carroll;Cell,2005

4. Demethylation of RB regulator MYPT1 by histone demethylase LSD1 promotes cell cycle progression in cancer cells;Cho;Cancer Res.,2011

5. Abiraterone and increased survival in metastatic prostate cancer;de Bono;N. Engl. J. Med.,2011

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanistic insights into steroid hormone-mediated regulation of the androgen receptor gene;PLOS ONE;2024-08-01

2. Androgen receptor post-translational modifications and their implications for pathology;Biochemical Society Transactions;2024-07-03

3. FOXA2 rewires AP-1 for transcriptional reprogramming and lineage plasticity in prostate cancer;Nature Communications;2024-06-08

4. FOXA1 and FOXA2: the regulatory mechanisms and therapeutic implications in cancer;Cell Death Discovery;2024-04-11

5. Chromatin activation with H3K36me2 and compartment shift in metastatic castration-resistant prostate cancer;Cancer Letters;2024-04